Blog

AKC_TMS-vs-Ketamine-Spravato-1200x800.webp

July 7, 2026

Depression and other mental health disorders like obsessive-compulsive disorder (OCD) are both common and serious. They affect how you feel, think, and function at home and work. When your symptoms don’t improve with traditional antidepressants and psychotherapy, it can feel discouraging.

Choosing between transcranial magnetic stimulation (TMS) and ketamine/Spravato can feel overwhelming, especially when you’re searching for relief after other treatments haven’t helped enough. While both are effective ways to treat a variety of disorders, both options work in very different ways:

  • TMS uses targeted magnetic stimulation to influence mood‑related brain circuits
  • Ketamine/Spravato acts chemically to rapidly shift patterns of thought and emotion.

Each has its own strengths, pace of improvement and ideal clinical fit.

At AwakeningsKC, we offer effective, proven outpatient therapies that help people reclaim their lives. Two of our leading therapies are transcranial magnetic stimulation and rapid-acting therapies such as ketamine and esketamine (Spravato).

Overview: How TMS and Ketamine/Spravato Work

Transcranial magnetic stimulation and ketamine/Spravato target the brain in very different but complementary ways to relieve treatment resistant depression and other disorders.

TMS

TMS is a noninvasive, FDA-cleared treatment that uses focused magnetic pulses to stimulate brain regions involved in mood regulation, often the prefrontal cortex. Sessions take place in our outpatient clinic while you are awake and seated.

A typical acute course involves short daily sessions five days per week for four to six weeks. Newer protocols can reduce session length while preserving clinical benefit.

Comparing Ketamine and Spravato

Ketamine and Spravato address mood through systemic pharmacology. Ketamine is often administered by intravenous infusion in specialized clinics. Spravato is the brand name for an FDA-approved nasal spray form of ketamine.v Ketamine therapy targets glutamate receptors and related pathways, rapidly modulating neural circuits that influence mood and cognition. Relief can begin within hours to days.

In simple terms, TMS delivers localized stimulation to specific cortical networks without circulating medication throughout the body. Ketamine and Spravato rely on medication absorbed into the bloodstream, with in-clinic monitoring during and after dosing.

A side-by-side comparison:

Feature TMS Ketamine/Spravato
How it works Localized magnetic stimulation of mood-related brain circuits Systemic medication that modulates glutamate and related pathways
Onset of effect Days to weeks; often noticeable by week 2–3 Hours to days after dosing
Course and maintenance Daily sessions for 4–6 weeks; maintenance or retreatment as needed Induction series followed by scheduled maintenance dosing
Common side effects Scalp discomfort, mild headache; no sedation or systemic side effects Dissociation, dizziness, nausea, transient blood pressure and heart rate rise
Monitoring needs No post-session observation; resume normal activities In-clinic supervision with observation; no driving until the next day
Candidacy considerations Non-systemic; useful for medication sensitivities or drug-interaction concerns Rapid relief prioritized; cardiovascular and psychiatric screening required
Insurance landscape Often covered for treatment-resistant depression Spravato is commonly covered under REMS; ketamine coverage varies by plan

TMS vs. Ketamine/Spravato: Do They Work?

Studies have shown that TMS therapy is at least partially effective over 50 percent of the time. Many people maintain improvement for months, and benefits can be extended with periodic maintenance or brief retreatment when needed. TMS typically builds over days to weeks and can be sustained with maintenance planning.

On the other hand, ketamine often acts faster. Some patients notice symptom relief within hours or days after the first dose, an advantage when depression is severe or rapidly worsening. Sustaining improvement usually requires completing a series of treatments and transitioning to maintenance dosing at intervals tailored to response.

TMS vs Ketamine/Spravato: Safety, Side Effects and Monitoring

TMS is well tolerated by most patients. Common, mild effects include

  • Scalp tenderness
  • Tapping sensations
  • Facial muscle twitching during stimulation
  • Headache that usually fades after the first few sessions

There is no sedation and no systemic side effects such as weight gain or sexual dysfunction. There is no downtime; most people return to normal activities immediately after treatment.

However, ketamine and Spravato can cause short-lived effects during or soon after dosing. These include changes in perception, dissociation, dizziness, nausea, and temporary increases in blood pressure and heart rate. Because of these effects, patients are monitored in clinic and typically need a ride home.

Driving and operating machinery should be avoided until the next day, or as directed by your care team.

TMS vs. Ketamine/Spravato: Who Is a Good Candidate?

TMS is often recommended for adults with mental health disorders who have not responded to one or more forms of treatment or who cannot tolerate side effects. It is a strong option for those with medication sensitivity, comorbid anxiety, or concerns about drug interactions with other medical treatments. Because TMS is non-systemic, it can be considered when minimizing overall medication exposure is a priority.

Ketamine may be considered when rapid relief is important, such as during severe episodes, elevated suicide risk or when multiple prior treatments have not worked. Suitability depends on a careful review of cardiovascular health, blood pressure, medication interactions, and psychiatric history.

People with uncontrolled hypertension, certain neurologic conditions, a history of adverse reactions to dissociative agents, or active substance misuse may need additional precautions or may be better served by another approach.

Age, pregnancy, and medical history influence selection as well. Because TMS does not involve systemic medication, it can be discussed in scenarios where limiting fetal exposure is important, though decisions during pregnancy always require individualized risk-benefit consultation with obstetric and psychiatric clinicians.

What to Expect: Experience, Timeline and Coverage

During a TMS session, you will sit comfortably while a small coil rests against your scalp. Sessions typically last between three and 20 minutes, depending on the protocol used. You can drive yourself to and from appointments and resume normal activities right away. The acute course generally runs five days per week for four to six weeks, with optional tapering or maintenance sessions based on response.

Ketamine and Spravato visits include pre-dose assessments, supervised administration, and post-dose observation. Time in clinic usually ranges from one to two hours or more. Due to ketamine’s side effects, transportation arrangements are required, and driving is avoided until the next day.

Treatment Timelines

Treatment schedules often begin with more frequent visits (for example, twice weekly) and shift to maintenance intervals as symptoms improve.

Timelines for improvement vary. Many TMS patients notice changes within the first two to three weeks, with continued gains toward the end of the course. Ketamine and Spravato may provide relief within hours to days, particularly helpful during crisis periods.

Both approaches can include maintenance strategies, like periodic TMS sessions or scheduled booster doses for Spravato or ketamine, to help sustain progress.

Coverage for TMS and Spravato

Coverage differs by insurer and medical policy. TMS is widely covered by many commercial plans and Medicare for treatment-resistant depression when criteria are met. Spravato is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior; coverage typically follows REMS and plan rules.

Our benefits team at AwakeningsKC helps you navigate authorizations and out-of-pocket estimates so there are no surprises.

TMS vs. Ketamine/Spravato: Which Is Better for Me?

The best choice depends on your goals, timeline, medical history and how you want treatment to fit into your life. If you value a noninvasive option with no systemic medication and minimal disruption to your routine, TMS may be a strong fit.

On the other hand, if you need rapid relief during a severe episode or crisis, Spravato or ketamine may offer faster symptom reduction, with a plan for maintenance dosing to sustain progress.

Some patients consider TMS and Spravato together across different phases of care. An example might be completing a TMS course for foundational improvement and using Spravato for focused booster support during periods of increased symptoms. Others begin with Spravato to stabilize quickly and transition to TMS to build durable gains without ongoing medication.

Our clinicians help you design a plan that aligns with your preferences and clinical needs.

Why Choose AwakeningsKC?

AwakeningsKC is a trusted leader in advanced outpatient care for depression and more. We specialize in TMS, ketamine and other mental health treatment, combining clinical expertise with a warm, welcoming approach. We believe compassionate care and rigorous science go hand in hand.

Here’s what you can expect with us:

  • Personalized evaluation that considers your history, current symptoms and goals
  • Clear guidance on treatment, including real-world timelines and outcomes
  • A safe, comfortable clinic with experienced teams who monitor progress closely
  • Benefits support, prior authorizations and transparent out-of-pocket estimates
  • Continuity of care with your referring providers and therapists

Relief is possible, even when prior treatments have not helped enough. Book an appointment with AwakeningsKC. We will listen carefully, review your options, and help you choose a path you feel confident about. Together, we’ll create a plan that supports long-term wellbeing.


 

Frequently Asked Questions

How do TMS and ketamine/Spravato feel during treatment?

TMS feels like rhythmic tapping on the scalp. Discomfort typically decreases after the first week. Ketamine and Spravato can cause short-lived changes in perception or awareness, along with nausea or dizziness; these are monitored in clinic with supportive care as needed.

Can I stay on my current medications?

Many patients continue antidepressants during TMS. For ketamine and Spravato, we review potential interactions and may adjust timing or dosing to maximize safety and benefit.

How long do benefits last?

TMS benefits often last several months following an acute course, and maintenance or brief retreatment can support continued wellness. For Spravato or ketamine, ongoing scheduled dosing is usually needed to maintain gains, with intervals tailored to individual response.

Is there downtime?

TMS requires no downtime; most people return to daily activities immediately. Ketamine and Spravato require in-clinic observation and no driving until the next day.

What if I also have anxiety?

Both approaches can help when anxiety accompanies depression. TMS is a good fit for those concerned about medication side effects. Ketamine or Spravato may be preferred when rapid reduction in distress is critical.


awakeningskc-logo.webp

July 13, 2021

Ketamine – that’s an anesthesia, isn’t it? Correct.

But did you know that in sub-anesthetic doses it is also a promising treatment option for pain and depression?

Let’s start at the beginning.

What is Ketamine and how does it work?

Ketamine is a medication primarily used for anesthesia. It is an antagonist of the NMDA receptors in the brain which are responsible for the anesthetic, analgesic and psychotomimetic effects. Although it’s not entirely clear how ketamine works in the treatment of depression, here’s what the scientists think. The binding of the NMDA receptors increase the neurotransmitter glutamate. This then activates the AMPA receptor.  Together, the blockade of NMDA receptors and activation of AMPA receptors leads to the release of other molecules that allow neurons to communicate better. This process is called synaptogenesis and synaptic potentiation, and is the process that is thought to affect mood, thought patterns and cognition.

What is Ketamine being used for in psychiatry?

Ketamine is being used for the management of treatment-resistant depression, bipolar disorder, obsessive compulsive disorder, and post-traumatic stress disorder.

How is Ketamine administered?

At this time, Ketamine is available in multiple formulations, although the intranasal (esketamine) and intravenous routes have the most compelling evidence for the treatment of depression. Whether intranasal or intravenous, repeated dosing is necessary to maintain a therapeutic benefit.

If you’re wondering which is better, there are no current head-to-head studies comparing the two.

Can Ketamine be used alone?

Multiple studies have demonstrated compelling evidence of Ketamine’s effect in treatment-resistant depression. Intranasal esketamine is typically co-administered with an antidepressive medication. Intravenous Ketamine can be administered as monotherapy or adjunctively with a psychotropic regimen.

How is Ketamine tolerated?

Overall, Ketamine is well-tolerated. It has a rapid onset (within 1-2 days) and has been shown to have a rapid reduction in suicidal ideation and depressive symptoms.

The most common side-effect noted with Ketamine administration is dissociation. Individuals describe it as a perceptual disturbance or “abnormal sensation”, but studies have shown no deficits in cognitive function with Ketamine use. For the most part, any changes in perception or dissociation are most noticeable during the first infusion and improve quickly afterward.

Other side effects include high blood pressure, nausea and vomiting.

At this time, the long-term effects of Ketamine are unknown.

In Conclusion…

Ketamine and esketamine represent novel treatment avenues for treatment-resistant depression and other psychiatric disorders. Although the long-term effects are still unknown, multiple studies have demonstrated the efficacy of sub-anesthetic doses of Ketamine in the treatment of psychiatric disorders.

Still have questions? Visit the Ketamine section of our website for more information.

If you are battling treatment-resistant depression and want to know if Ketamine is a treatment option for you, call (913) 381-8555 and make an appointment.

 

References:

McIntyre RS, et al. Synthesizing the evidence of ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry 2021;178:383-399.

Moda-Sava RN, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 2019;Vol 364, Issue 6436


90-2-1200x800.jpeg

July 5, 2020 0

Alcohol use disorder (AUD), or alcoholism, affects more than 14 million individuals over the age of 18 in the United States alone.1 AUD is described as a chronic brain disease that is characterized by compulsive drinking, loss of control over the consumption of alcohol, and experiencing negative emotions when not using alcohol.2

The treatment of AUD typically starts with detox. For individuals with a physiological dependence to alcohol, the abrupt cessation of drinking could result in serious complications, such as alcohol withdrawal seizures. A supervised medical detox, whether inpatient or outpatient, is always recommended.3

So I’ve completed detox, what’s next? 

Treatment programs, like Awakenings KC, will employ various modalities to assist in continued abstinence from alcohol. These include, but are not limited to, behavioral therapy, family therapy, and/or the treatment of co-occurring disorders.

An additional treatment for alcohol addiction offered by Dr. Davila at Awakenings KC is ketamine infusion therapy.

What is ketamine?

Ketamine is an anesthetic medication that acts on the central nervous system through antagonism of the N-Methyl-D-Aspartate (NMDA) receptor.4-6 Ketamine is different than other anesthetics in that it has a good safety profile and lacks the major drawback of respiratory depression.5

Over the past decade, it has been increasingly used in the treatment of depression and addiction. How does it work? Well, scientists are not 100% sure, but several mechanisms have been proposed and substantiated with research. Several animal and human models have demonstrated that ketamine can rewrite maladaptive reward memories, enhance neuroplasticity and neurogenesis, and enhance psychological therapy efficacy.4-6

Ketamine in the treatment of addiction.

Ketamine has shown promising results in the treatment of addiction.4-6 Studies have shown that ketamine infusion can promote abstinence from alcohol and reduce cravings. In recently detoxified alcoholics, abstinence rates increased from 24% to 66% in the ketamine group.7

Although ketamine itself has been utilized as a drug of abuse, in sub-anesthetic doses, it is not “rewarding”. In multiple studies, there were no patients that went on to abuse ketamine following their infusion treatments.6

In summary…

Ketamine has been shown to increase synaptogenesis and neuroplasticity.6 What does this mean? It helps restructure and reorganize the brain at a cellular level, helping to reverse the changes that are associated with depression and addiction.

Ketamine is safe, effective, and shows promising results in the treatment of depression and addiction.

If you’re interested in more information about ketamine infusions, check out the Awakenings KC website here or call for a consultation – (913) 381-8555.

 

References:

  1. Alcohol facts and statistics – NIH
  2. Alcohol abuse and addiction – NIH
  3. Alcoholism treatment: what is alcohol abuse and how to treat alcoholism – American Addiction Centers
  4. Das RK, Grace G, Walsh K, et al. Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nature communications. 2019;10:5187.
  5. Ezquerra-Romano I, Lawn W, Krupitsky E, et al. Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology. 2018;142:72-82.
  6. McAndrew A, Lawn W, Stevens T, et al. A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomized controlled trial. Trials. 2017;18:159.
  7. Krupitsky EM, Burakov AM, Romanova TN, et al. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. Neuropsychopharmacology. 2001;6:936-47.

 

 


For Life-Threatening Emergencies Call 911
 
Here at Awakenings we pride ourselves in restoring hope. Please contact us to begin your journey today.

Location

Awakenings KC
5300 W 94th Terrace #200,
Prairie Village, KS 66207

Select Language

X